Parotitis epidemiology and demographics
|
Parotitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Parotitis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Parotitis epidemiology and demographics |
|
Risk calculators and risk factors for Parotitis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Epidemiology and Demographics
Incidence
- Viral parotitis (mumps): The global incidence of mumps in 2014 was 0.24 per 100,000 individuals.[1][2]
Prevalence
- [Sjögren’s Syndrome]]: The prevalence of Sjögren’s syndrome, as of 2015, is 1000 per 100,000 individuals in the United States.[3]
Age
- Viral parotitis is most commonly found in children that have not yet received the mumps vaccine, between 12 months and 6 years old.[4]
- Mumps outbreaks, and resultant parotitis, is seen in young adults between 20-30 years old due to being too old for vaccination, yet too young to have natural exposure to infection.[5]
- Juvenile recurrent parotitis most commonly affects children between 12 months and 16 years old.[6]
- [Sjögren’s syndrome is primarily found in women at the perimenopausal age.[3]
Gender
- Parotitis from [Sjögren’s syndrome is 9 times more likely to affect females.[7]
- Juvenile recurrent parotitis is more common in boys.[6]
Developed countries
- Parotitis from mumps is rare in developed countries, as use of the vaccination is widespread.[8]
- Parotitis from mumps outbreaks in developed countries are usually due to the following:[9]
- Lack of follow-up vaccination
- Non-vaccinated children not developing a resistance to the infection due to lack of natural exposure
- Vaccine-resistant viral strain
Developing countries
- Parotitis is more common in developing countries due to the lower vaccinated population.[8]
Race
- There is no racial predilection to parotitis.
References
- ↑ "WHO World Health Organization: Immunization, Vaccines And Biologicals. Vaccine preventable diseases Vaccines monitoring system 2015 Global Summary Reference Time Series: MUMPS".
- ↑ "Population Clock: World".
- ↑ 3.0 3.1 Cartee DL, Maker S, Dalonges D, Manski MC (2015). "Sjögren's Syndrome: Oral Manifestations and Treatment, a Dental Perspective". J Dent Hyg. 89 (6): 365–71. PMID 26684993.
- ↑ "Mumps | Vaccination | CDC".
- ↑ Hviid A, Rubin S, Mühlemann K (2008). "Mumps". Lancet. 371 (9616): 932–44. doi:10.1016/S0140-6736(08)60419-5. PMID 18342688.
- ↑ 6.0 6.1 Nahlieli O, Shacham R, Shlesinger M, Eliav E (2004). "Juvenile recurrent parotitis: a new method of diagnosis and treatment". Pediatrics. 114 (1): 9–12. PMID 15231901.
- ↑ "Sjogren's Syndrome: MedlinePlus".
- ↑ 8.0 8.1 Galazka AM, Robertson SE, Kraigher A (1999). "Mumps and mumps vaccine: a global review". Bull. World Health Organ. 77 (1): 3–14. PMC 2557572. PMID 10063655.
- ↑ Sabbe M, Vandermeulen C (2016). "The resurgence of mumps and pertussis". Hum Vaccin Immunother. doi:10.1080/21645515.2015.1113357. PMID 26751186.